Mid-Term Outcomes of Common Femoral Patch Angioplasty in Iliofemoral Occlusive Diseases: Bovine Pericardial Patch Versus Great Saphenous Vein Patch
Ann Vasc Surg. 2025 Jan 27;114:106-115. doi: 10.1016/j.avsg.2024.12.075. Online ahead of print.
ABSTRACT
BACKGROUND: To assess the mid-term outcomes of using bovine pericardium patch (BPP) compared to great saphenous vein patch (GSVP) in femoral angioplasty for iliofemoral occlusive diseases.
METHODS: A retrospective study was carried out at the First Medical Center of the Chinese PLA General Hospital from January 2013 to July 2023 to assess the efficacy of femoral angioplasty in patients with iliofemoral occlusive disease. Technical success, early outcomes, 24-month primary patency, and freedom from restenosis at the patch site were evaluated. Propensity score matching was employed to improve comparability between the BPP and GSVP groups.
RESULTS: A total of 81 patients (91 limbs) were included in the study; 2 groups were created according to the type of patch used with 35 patients (42 limbs) in the BPP group and 46 patients (49 limbs) in the GSVP group. Common femoral angioplasty was a fixed step in all cases. Technical success was achieved in all cases, with no perioperative mortality. The perioperative complication rate was 14.3%. Kaplan-Meier curves showed comparable primary patency and freedom from restenosis between the BPP and GSVP groups with or without propensity score matching.
CONCLUSION: It may be a viable option to choose BPP in femoral angioplasty for patients who cannot provide GSVP.
PMID:39880282 | DOI:10.1016/j.avsg.2024.12.075